Robert W. Carey

8.1k total citations · 1 hit paper
106 papers, 5.3k citations indexed

About

Robert W. Carey is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Robert W. Carey has authored 106 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 41 papers in Oncology and 22 papers in Epidemiology. Recurrent topics in Robert W. Carey's work include Lung Cancer Research Studies (15 papers), Neuroendocrine Tumor Research Advances (14 papers) and Lung Cancer Treatments and Mutations (14 papers). Robert W. Carey is often cited by papers focused on Lung Cancer Research Studies (15 papers), Neuroendocrine Tumor Research Advances (14 papers) and Lung Cancer Treatments and Mutations (14 papers). Robert W. Carey collaborates with scholars based in United States, Canada and France. Robert W. Carey's co-authors include Noah C. Choi, Michael C. Perry, Walter L. Eaton, Kathleen J. Propert, Mark R. Green, Stephen L. Seagren, Emil Frei, Douglas J. Mathisen, Julio Guerra and Robert O. Dillman and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Robert W. Carey

101 papers receiving 5.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer

1990 882 citations Robert O. Dillman, Stephen L. Seagren et al. New England Journal of Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Robert W. Carey	2.6k	2.4k	1.1k	835	828	106	5.3k
A. B. Miller	2.4k 0.9×	3.6k 1.5×	1.4k 1.3×	706 0.8×	491 0.6×	6	6.8k
P. Kosmidis	2.3k 0.9×	3.9k 1.6×	1.0k 1.0×	636 0.8×	734 0.9×	224	6.4k
Arthur T. Skarin	2.4k 0.9×	2.7k 1.1×	531 0.5×	798 1.0×	314 0.4×	122	5.4k
Bruce J. Roth	1.7k 0.7×	2.1k 0.9×	2.7k 2.6×	773 0.9×	462 0.6×	124	5.8k
Ashley E. Winkler	2.5k 1.0×	3.9k 1.6×	1.4k 1.3×	731 0.9×	495 0.6×	12	7.3k
Heine H. Hansen	2.6k 1.0×	4.1k 1.7×	796 0.7×	2.1k 2.5×	309 0.4×	205	6.6k
Saul E. Rivkin	2.0k 0.8×	3.6k 1.5×	971 0.9×	647 0.8×	265 0.3×	127	5.8k
Scot C. Remick	1.0k 0.4×	2.8k 1.2×	656 0.6×	781 0.9×	470 0.6×	156	6.1k
Barth Hoogstraten	3.0k 1.2×	4.9k 2.1×	1.6k 1.5×	820 1.0×	910 1.1×	79	9.5k
Vincent J. Picozzi	951 0.4×	3.2k 1.3×	792 0.7×	574 0.7×	545 0.7×	130	4.5k

Countries citing papers authored by Robert W. Carey

Since Specialization

Citations

This map shows the geographic impact of Robert W. Carey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. Carey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. Carey more than expected).

Fields of papers citing papers by Robert W. Carey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert W. Carey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. Carey. The network helps show where Robert W. Carey may publish in the future.

Co-authorship network of co-authors of Robert W. Carey

This figure shows the co-authorship network connecting the top 25 collaborators of Robert W. Carey. A scholar is included among the top collaborators of Robert W. Carey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert W. Carey. Robert W. Carey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Choi, Noah C. & Robert W. Carey. (2015). Reassessment of Loco-Regional Failure Rate in Relation with Radiation Dose in Combined Modality Approach of Multidrug Chemotherapy and Radiotherapy for Limited-Stage Small-Cell Lung Carcinoma. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 41. 70–76.

Choi, Noah C., Cameron D. Wright, John C. Wain, et al.. (2000). Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study. International Journal of Radiation Oncology*Biology*Physics. 46(4). 927–933. 86 indexed citations

Choi, Noah C., James E. Herndon, Julian Rosenman, et al.. (1998). Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.. Journal of Clinical Oncology. 16(11). 3528–3536. 136 indexed citations

Maurer, L. Herbert, James E. Herndon, Donna Hollis, et al.. (1997). Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study.. Journal of Clinical Oncology. 15(11). 3378–3387. 101 indexed citations

Brugge, William R., Michael J. Lee, Robert W. Carey, & Douglas J. Mathisen. (1997). Endoscopic ultrasound staging criteria for esophageal cancer. Gastrointestinal Endoscopy. 45(2). 147–152. 30 indexed citations

Choi, Noah C., Robert W. Carey, William J. Daly, et al.. (1997). Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer.. Journal of Clinical Oncology. 15(2). 712–722. 211 indexed citations

Mathisen, Douglas J., John C. Wain, Cameron D. Wright, et al.. (1996). Assessment of preoperative accelerated radiotherapy and chemotherapy in stage IIIa (N2) non-small-cell lung cancer. Journal of Thoracic and Cardiovascular Surgery. 111(1). 123–133. 42 indexed citations

Fidias, Panos, Robert W. Carey, & Michael L. Grossbard. (1995). Non-hodgkin's lymphoma presenting with biliary tract obstruction. A discussion of seven patients and a review of the literature. Cancer. 75(7). 1669–1677. 32 indexed citations

Wright, Cameron D., Douglas J. Mathisen, John C. Wain, et al.. (1994). Evolution of treatment strategies for adenocarcinoma of the esophagus and gastroesophageal junction. The Annals of Thoracic Surgery. 58(6). 1574–1579. 33 indexed citations

10.

Silverman, Lewis R., James F. Holland, RS Weinberg, et al.. (1993). Effects of treatment with 5-azacytidine on the in vivo and in vitro hematopoiesis in patients with myelodysplastic syndromes.. PubMed. 7 Suppl 1. 21–9. 169 indexed citations

11.

Carey, Robert W., Alan D. Hilgenberg, Earle W. Wilkins, et al.. (1993). Long-Term Follow-Up of Neoadjuvant Chemotherapy with 5-Fluorouracil and Cisplatin with Surgical Resection and Possible Postoperative Radiotherapy and /or Chemotherapy in Squamous Cell Carcinoma of the Esophagus. Cancer Investigation. 11(2). 99–105. 33 indexed citations

12.

Case, Delvyn C., Robert W. Carey, David H. Henry, et al.. (1993). Recombinant Human Erythropoietin Therapy for Anemic Cancer Patients on Combination Chemotherapy. JNCI Journal of the National Cancer Institute. 85(10). 801–806. 154 indexed citations

13.

Fishman, James R., Michael E. Moran, & Robert W. Carey. (1993). Obturator neuropathy after laparoscopic pelvic lymphadenectomy. Urology. 42(2). 198–200. 23 indexed citations

14.

Case, Delvyn C., María Teresa Santarelli, Robert W. Carey, James Anderson, & Arlan J. Gottlieb. (1992). Phase II trial of ifosfamide/mesna and mitoxantrone in previously treated patients with non‐Hodgkin's lymphoma: Cancer and leukemia group B study 8753. Medical and Pediatric Oncology. 20(4). 325–329. 3 indexed citations

15.

Dawson, Nancy A., Mary E. Costanza, Ann H. Korzun, et al.. (1991). Trimetrexate in untreated and previously treated patients with metastatic breast cancer: A cancer and leukemia group b study. Medical and Pediatric Oncology. 19(4). 283–288. 11 indexed citations

16.

Carey, Robert W., Alan D. Hilgenberg, Douglas J. Mathisen, et al.. (1991). A pilot study of neoadjuvant chemotherapy with 5-fluorouracil and cisplatin with surgical resection and postoperative radiation therapy and/or chemotherapy in adenocarcinoma of the esophagus. Cancer. 68(3). 489–492. 23 indexed citations

17.

Dillman, Robert O., Stephen L. Seagren, Kathleen J. Propert, et al.. (1990). A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer. New England Journal of Medicine. 323(14). 940–945. 882 indexed citations breakdown →

18.

Carey, Robert W. & Nancy L. Harris. (1989). Thrombotic microangiopathy in three patients with cured lymphoma. Cancer. 63(7). 1393–1397. 8 indexed citations

19.

Perloff, Michael, Gerson Lesnick, Florence C. H. Chu, et al.. (1988). Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: a Cancer and Leukemia Group B study.. Journal of Clinical Oncology. 6(2). 261–269. 139 indexed citations

20.

Bosl, George J., Nancy L. Geller, Dean F. Bajorin, et al.. (1988). A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.. Journal of Clinical Oncology. 6(8). 1231–1238. 183 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact